Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.

about

Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.

Item

http://www.wikidata.org/entity/Q51615169

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Ezetimibe increases intestinal ...... c men with insulin resistance.

@en

Ezetimibe increases intestinal ...... c men with insulin resistance.

@nl

type

Item

label

Ezetimibe increases intestinal ...... c men with insulin resistance.

@en

Ezetimibe increases intestinal ...... c men with insulin resistance.

@nl

prefLabel

Ezetimibe increases intestinal ...... c men with insulin resistance.

@en

Ezetimibe increases intestinal ...... c men with insulin resistance.

@nl

P1476

Ezetimibe increases intestinal ...... ic men with insulin resistance

@en

P2093

André J Tremblay

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Drouin-Chartier

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Lépine

http://www.w3.org/2001/XMLSchema#string

Valéry Lemelin

http://www.w3.org/2001/XMLSchema#string

P2860

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

Estrogen receptors and the metabolic network.

Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.

Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

P304

1226-1235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.12749

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benoît Lamarche

Patrick Couture

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27460541

http://www.w3.org/2001/XMLSchema#string